#11 Click this link to see News Photos page --> 12/10/2023 #2
 | The Food and Drug Administration on Friday approved a new sickle cell disease treatment using the CRISPR genome editing technology. Its the 1st approved human gene editing therapy. Sickle cell disease affects approximately 100,000 people in the U.S. |
 MjL
|
 Coincidence? Sickle cell disease is more common in certain ethnic groups, including: People of African descent, including African-Americans (among whom 1 in 12 carries a sickle cell gene) Hispanic-Americans from Central and South America. People of Middle Eastern, Asian, Indian, and Mediterranean descent. |
Michael T.
|
 | We watched a segment about this on the evening news the other day and Tracey mentioned how there was very little available to treat this disease. I would say to follow the money. I wonder what changed to make this treatment profitable. |
MjL
|
|